Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113702772 | 11370277 | 2 | F | 20160824 | 20150812 | 20160826 | EXP | FR-JNJFOC-20150806616 | JANSSEN | ABRIC CC, SAADOUN D, BIARD L, SENE D, RESCHE-RIGON M, HERVIER B, ET AL. LONG-TERM OUTCOME OF INFLIXIMAB IN SEVERE CHRONIC AND REFRACTORY SYSTEMIC SARCOIDOSIS: A REPORT OF 16CASES. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY JUL-2015;33(4):509-15. CHAPELON C, SAADOUN D, BIARD L, RESCHE-RIGON M, HERVIER B, COSTEDOAT-CHALUMEAU N, ET AL. LONG TERM OUTCOME OF INFLIXIMAB IN SEVERE AND REFRACTORY SYSTEMIC SARCOIDOSIS: REPORT OF 16 CASES. ARTHRITIS AND RHEUMATOLOGY 2014 ACR/ARHP ANNUAL MEETING BOSTON, MA UNI | 0.00 | Y | 0.00000 | 20160826 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113702772 | 11370277 | 1 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 3 OR 5 MG EVERY 0,2,6 AND THEN EVERY 8 WEEKS | Y | N | 103772 | LYOPHILIZED POWDER | |||||||
| 113702772 | 11370277 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
| 113702772 | 11370277 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113702772 | 11370277 | 1 | Sarcoidosis |
| 113702772 | 11370277 | 2 | Sarcoidosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113702772 | 11370277 | OT |
| 113702772 | 11370277 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113702772 | 11370277 | Lung infection | |
| 113702772 | 11370277 | Osteoporosis | |
| 113702772 | 11370277 | Product use issue | |
| 113702772 | 11370277 | Sarcoidosis | |
| 113702772 | 11370277 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |